Vergara, Mercedes

Publishing since 1995 (Senior)

Has published 47 publications in 16 years

Number of publications published per year by Vergara, Mercedes. (Source : PubMed)

Distribution of publications types for Vergara, Mercedes. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Cohen H, Tomasso G, Luisa Cafferata M, Zapata C, Sharma P, Armstrong D, Moraes-Filho JP, Blasco C, Corti R, Estape G, Leite Luna L, Ortuño R, Sakai P, Salis G, Taullard D, Trakal E, Valdovinos M, Vergara M, Gónzalez O. Latin american consensus on gastroesophageal reflux disease: an update on therapy.  Gastroenterol Hepatol  2010;33;2  
•  Quiroga M, Lezcano MT, Martin Talavera B, Cáceres MG, Vergara M. Beta-lactam resistance in variants of Aeromonas spp. selected in vitro under antibiotic pressure.  J Chemother  2009;21;6  
•  Calvet X, Motos J, Montserrat A, Gallardo O, Vergara M. Analysis of court criteria for awarding disability benefits to patients with Crohn's disease.  Clin. Gastroenterol. Hepatol.  2009;7;12  
•  Vergara M, Montserrat A, Casellas F, Maudsley M, Gallardo O, Ricart E, Calvet X. Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.  Eur J Gastroenterol Hepatol  2009;21;7  
•  Bejarano G, Vergara M, Dalmau B, Puig J, Bella MR, Suárez D, Calvet X. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.  Rev Esp Enferm Dig  2009;101;5  
•  Vergara M, Gil M, Dalmau B, Ribot R, Navarro C, Martín A, Penafreta M, Puig J, Martín J, Perendreu J, Falcó J, Bella R. [Natural history of hepatocellular carcinoma in a cohort of pacients from a county hospital]  Rev Esp Enferm Dig  2008;100;11  
•  Villoria A, Garcia P, Calvet X, Gisbert JP, Vergara M. Meta-analysis: high-dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication.  Aliment. Pharmacol. Ther.  2008;28;7  
•  Cereto F, Herranz X, Moreno E, Andreu A, Vergara M, Fontanals D, Roget M, Simó M, González A, Prats G, Genescà J. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.  Eur J Gastroenterol Hepatol  2008;20;9  
•  Vergara M, Gallach M, Dalmau B, Gil M, Miquel M, Rudi N, Gavarro A, Cebollero A, Masip M, Real J. [Results of pegylated interferon and ribavirin for the treatment of chronic hepatitis C in clinical practice: a 5-year experience]  Gastroenterol Hepatol  2008;31;5  
•  Calvet X, Villoria A, Vergara M. Could increasing the duration of triple therapy be a clinically useful strategy?  Ann. Intern. Med.  2008;148;8  

[ See timeline ] [ See all publications ]